Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Deep Dive: Upper Digestive Cancers - Biliary Cancer

Aired live on 06 Jul 2022


ESMO Deep Dive: Upper Digestive Cancers - Biliary Cancer

Chair: Andrew Ko, Angela Lamarca
Speakers: Marina Baretti, Rachna Shroff, Arndt Vogel

(Reserved to ESMO Members)

This content is for ESMO members only.


ESMO Members: Take the CME test
and receive 2 ESMO - MORA point

Learning objectives:

  • To understand the pathogenesis of biliary cancers and how underlying liver disease contributes to the development of such cancers and may inform treatment
  • To describe mutations and other genetic alterations that inform the current use of both targeted and immune-based therapies in biliary cancers
  • To learn about emerging biomarkers under investigation that hold promise for novel drug development in this disease

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.